SEER, INC. Investing Cash Flow
SEER, INC. (SEER) reported Investing Cash Flow of $6.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-11
- SEER, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$11.47M, a 255.74% decline year-over-year.
- SEER, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $18.08M, a 26.55% decline year-over-year.
- SEER, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $12.98M, a 18.11% decline year-over-year.
- SEER, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $16.60M, a 37.22% decline year-over-year.
- SEER, INC. net cash provided by (used in) investing activities for fiscal 2025 was $61.55M, a 6.54% decline from fiscal 2024.
- SEER, INC. net cash provided by (used in) investing activities for fiscal 2024 was $65.86M, a 73.75% increase from fiscal 2023.
- SEER, INC. net cash provided by (used in) investing activities for fiscal 2023 was $37.90M.
- SEER, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$122.72M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$11.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $6.61M 10-Q · filed 2026-08-11 | $19.59M derived: sum of 3 quarters · filed 2026-08-11 | $36.18M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $18.08M 10-Q · filed 2026-05-13 | $31.05M derived: sum of 2 quarters · filed 2026-05-13 | $47.65M derived: sum of 3 quarters · filed 2026-05-13 | $55.01M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $12.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $29.57M derived: sum of 2 quarters · filed 2026-03-02 | $36.94M derived: sum of 3 quarters · filed 2026-08-11 | $61.55M 10-K · filed 2026-03-02 |
| 2025-09-30 | $16.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $23.96M derived: sum of 2 quarters · filed 2026-08-11 | $48.57M 10-Q · filed 2025-11-06 | $64.42M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $7.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $31.97M 10-Q · filed 2026-08-11 | $47.82M derived: sum of 3 quarters · filed 2026-08-11 | $74.26M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $24.61M 10-Q · filed 2026-05-13 | $40.46M derived: sum of 2 quarters · filed 2026-05-13 | $66.90M derived: sum of 3 quarters · filed 2026-05-13 | $58.11M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $15.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $42.28M derived: sum of 2 quarters · filed 2026-03-02 | $33.50M derived: sum of 3 quarters · filed 2026-03-02 | $65.86M 10-K · filed 2026-03-02 |
| 2024-09-30 | $26.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $17.66M derived: sum of 2 quarters · filed 2025-11-06 | $50.01M 10-Q · filed 2025-11-06 | $56.12M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$8.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $23.57M 10-Q · filed 2025-08-06 | $29.68M derived: sum of 3 quarters · filed 2025-08-06 | $24.06M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $32.35M 10-Q · filed 2025-05-13 | $38.47M derived: sum of 2 quarters · filed 2025-05-13 | $32.84M derived: sum of 3 quarters · filed 2025-05-13 | $55.78M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $6.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $486.00K derived: sum of 2 quarters · filed 2025-03-03 | $23.43M derived: sum of 3 quarters · filed 2025-03-03 | $37.90M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$5.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $17.31M derived: sum of 2 quarters · filed 2024-11-06 | $31.79M 10-Q · filed 2024-11-06 | $29.08M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $22.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $37.42M 10-Q · filed 2024-08-08 | $34.71M derived: sum of 3 quarters · filed 2024-08-08 | $36.96M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $14.48M 10-Q · filed 2024-05-08 | $11.77M derived: sum of 2 quarters · filed 2024-05-08 | $14.02M derived: sum of 3 quarters · filed 2024-05-08 | -$119.16M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | -$461.00K derived: sum of 2 quarters · filed 2024-03-04 | -$133.64M derived: sum of 3 quarters · filed 2024-03-04 | -$122.72M 10-K · filed 2024-03-04 |
| 2022-09-30 | $2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$130.93M derived: sum of 2 quarters · filed 2023-11-07 | -$120.01M 10-Q · filed 2023-11-07 | -$207.50M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$133.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$122.26M 10-Q · filed 2023-08-08 | -$209.75M derived: sum of 3 quarters · filed 2023-08-08 | -$240.87M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $10.92M 10-Q · filed 2023-05-09 | -$76.57M derived: sum of 2 quarters · filed 2023-05-09 | -$107.69M derived: sum of 3 quarters · filed 2023-05-09 | -$171.84M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$87.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$118.61M derived: sum of 2 quarters · filed 2023-03-06 | -$182.76M derived: sum of 3 quarters · filed 2023-03-06 | -$170.88M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$31.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$95.27M derived: sum of 2 quarters · filed 2022-11-08 | -$83.39M 10-Q · filed 2022-11-08 | -$78.12M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$64.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$52.26M 10-Q · filed 2022-08-09 | -$46.99M derived: sum of 3 quarters · filed 2022-08-09 | -$97.09M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $11.88M 10-Q · filed 2022-05-06 | $17.16M derived: sum of 2 quarters · filed 2022-05-06 | -$32.95M derived: sum of 3 quarters · filed 2022-05-06 | -$25.63M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $5.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$44.83M derived: sum of 2 quarters · filed 2022-03-01 | -$37.51M derived: sum of 3 quarters · filed 2022-03-01 | -$34.56M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$50.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$42.78M derived: sum of 2 quarters · filed 2021-11-09 | -$39.83M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $7.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $10.27M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $2.95M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |